Lighthouse Investment Partners’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Lighthouse Investment Partners’s Portfolio OACCU Stock Details OACCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300,000	Closed	-$3.13M	–	717
2025 Q1	$3.13M	Buy	+300,000	New	+$3.06M	0.13%	201

Other funds holding OACCU

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lighthouse Investment Partners's OACCU Position: Q2 2025 in Review

Lighthouse Investment Partners sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2025, closing a stake of 300,000 shares — an estimated $3.13M sold.

Lighthouse Investment Partners first reported a position in OACCU in Q1 2025 and held it in 1 quarter. The position peaked at $3.13M in Q1 2025. 6 funds tracked by Wall St. Rank hold OACCU as of Q2 2025.

Lighthouse Investment Partners reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2025 after selling out during the quarter.
Lighthouse Investment Partners sold 300,000 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2025, an estimated $3.13M.
Lighthouse Investment Partners first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q1 2025 and held it in 1 quarter.
Lighthouse Investment Partners's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $3.13M in Q1 2025.
6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2025.

Based on Lighthouse Investment Partners's 13F filing for Q2 2025, filed 14 Aug 2025.